ZYX and neoplasm: Expression of the MRTF-SRF transcription pathway-linked target genes, such as caldesmon, tropomyosin, vinculin, and zyxin, are reduced in certain tumor cells, and their forced re-expression reverses many malignant phenotypes of tumor cells [11, 12].